Published :
Tables : 70
Figures : 48
Category : Healthcare
No. of Pages : 200
Report Code : HC-1189
Bioinformatics Market Introduction: Bioinformatics market is estimated to value over USD 18 billion with a CAGR of over 13.5% from the forecast period 2020 to 2027. The use of advanced computerized systems for the analysis of biological or genetic data is essentially bioinformatics. The system is useful for next-generation sequencing (NGS), gene coding, transcriptomics, forensic science and so on. Being a stream of genetics, the market has shown remarkable growth since the past years. The increasing scope in research and development, new advancements in genetics analysis and synthesis methods and techniques are the factors responsible for the expansion of the market size. Based on the products and services, the market is segmented into knowledge management tools, bioinformatics platforms, and bioinformatics services. The preference for bioinformatics platforms is massive across the globe. The efficacy of results and ease of operation in data analysis, gene sequencing, software analysis are the key features for the rising demand for bioinformatics platforms and are influencing the market growth and CAGR positively. The bioinformatics market has a wide application range in the genomics segment. Library preparation, DNA sequencing, target enrichment, PCR techniques, etc. are the major applications and hence preferred by pharmaceutical and biotechnological companies across the globe. The transcriptomics segment is growing rapidly owing to expenditures assigned and new advancements related to transcriptomics. Expenditure and investments on drug discovery are mounting the market growth. Inclination towards collaborating with genetics research organizations is the key element responsible for the large market share of medical biotechnology. Owing to the rising concerns for promoting agricultural investments, government organizations are focusing on the development of current agricultural projects. This sector has a wide scope in the future market of bioinformatics. The bioinformatics market in North America is estimated to hold a large share globally. The availability of advanced technology and favourable research environment boosts the market in this region. Furthermore, the Asia Pacific region has a rising demand for the market. Major key players in the market are Thermo Fisher Scientific, Eurofins Scientific, Illumina, Agilent Technologies, Geneva Bioinformatics (Genebio), Dassault Systems, Bruker Daltonics , Biomax Informatics AG, Perkinelmer , Qiagen N.V, Accelrys , Affymetrix, SA Nonlinear Dynamics, Quest Diagnostics and IBM Life Sciences and so on. Thermo Fisher Scientific has a range of advanced products for protein biology, cell analysis, cell culture, sequencing, and so on. The availability of the most preferred products and methods is the key factor. FutureWise Key Takeaways: Investments in bioinformatics research Focus on bioinformatics platforms Collaborations with key market players across the globe Bioinformatics Market Segmentation: By Product and Service Knowledge management tools Bioinformatics platforms Bioinformatics services By Application Genomics Chemoinformatics and drug design Proteomics Transcriptomics Metabolomics Other bioinformatics applications By Sector Medical biotechnology Academics Agricultural biotechnology Environmental biotechnology Forensic biotechnology Others By Region North America Europe Asia Pacific Rest of the World Competitive Landscape: Tier 1 players- established companies in the market with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants Objectives of the Study: To provide with an exhaustive analysis on the bioinformatics market by product and service, by application, by sector and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, and the rest of the world To record evaluate and competitive landscape mapping-product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Bioinformatics market is estimated to value over USD 18 billion with a CAGR of over 13.5% from the forecast period 2020 to 2027.
The use of advanced computerized systems for the analysis of biological or genetic data is essentially bioinformatics. The system is useful for next-generation sequencing (NGS), gene coding, transcriptomics, forensic science and so on. Being a stream of genetics, the market has shown remarkable growth since the past years.
The increasing scope in research and development, new advancements in genetics analysis and synthesis methods and techniques are the factors responsible for the expansion of the market size.
Based on the products and services, the market is segmented into knowledge management tools, bioinformatics platforms, and bioinformatics services. The preference for bioinformatics platforms is massive across the globe. The efficacy of results and ease of operation in data analysis, gene sequencing, software analysis are the key features for the rising demand for bioinformatics platforms and are influencing the market growth and CAGR positively.
The bioinformatics market has a wide application range in the genomics segment. Library preparation, DNA sequencing, target enrichment, PCR techniques, etc. are the major applications and hence preferred by pharmaceutical and biotechnological companies across the globe. The transcriptomics segment is growing rapidly owing to expenditures assigned and new advancements related to transcriptomics.
Expenditure and investments on drug discovery are mounting the market growth. Inclination towards collaborating with genetics research organizations is the key element responsible for the large market share of medical biotechnology. Owing to the rising concerns for promoting agricultural investments, government organizations are focusing on the development of current agricultural projects. This sector has a wide scope in the future market of bioinformatics.
The bioinformatics market in North America is estimated to hold a large share globally. The availability of advanced technology and favourable research environment boosts the market in this region. Furthermore, the Asia Pacific region has a rising demand for the market.
Major key players in the market are Thermo Fisher Scientific, Eurofins Scientific, Illumina, Agilent Technologies, Geneva Bioinformatics (Genebio), Dassault Systems, Bruker Daltonics , Biomax Informatics AG, Perkinelmer , Qiagen N.V, Accelrys , Affymetrix, SA Nonlinear Dynamics, Quest Diagnostics and IBM Life Sciences and so on. Thermo Fisher Scientific has a range of advanced products for protein biology, cell analysis, cell culture, sequencing, and so on. The availability of the most preferred products and methods is the key factor.
FutureWise Key Takeaways:
Bioinformatics Market Segmentation:
By Product and Service
By Application
By Sector
By Region
Competitive Landscape:
Objectives of the Study:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Bioinformatics Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Bioinformatics Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Bioinformatics on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Bioinformatics Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Bioinformatics Market, By Product and Service Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Knowledge management tools 7.2. Bioinformatics platforms 7.3. Bioinformatics services 8. Global Bioinformatics Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Genomics 8.2. Chemoinformatics and drug design 8.3. Proteomics 8.4. Transcriptomics 8.5. Metabolomics 8.6. Other bioinformatics applications 9. Global Bioinformatics Market, By Distribution Channel Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Medical biotechnology 9.2. Academics 9.3. Agricultural biotechnology 9.4. Environmental biotechnology 9.5. Forensic biotechnology 9.6. Others 10. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2020-2027 11. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Regional Market Trends 11.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.3.1. Brazil 11.3.2. Venezuela 11.3.3. Argentina 11.3.4. Rest of Latin America 11.4. Market Size (USD Million) Forecast for Latin America 2020-2027 12. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Switzerland 12.2.9. Rest of Western Europe 12.3. Market Size (USD Million) Forecast for Europe 2020-2027 13. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Japan 13.2.2. China 13.2.3. Singapore 13.2.4. India 13.2.5. Australia and New Zealand 13.2.6. ASEAN 13.2.7. South Korea 13.2.8. Taiwan 13.2.9. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 14. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Saudi Arabia 14.2.2. UAE 14.2.3. South Africa 14.2.4. Egypt 14.3. Market Size (USD Million) Forecast for MEA 2020-2027 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 15.1. Thermo Fisher Scientific 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. Eurofins Scientific 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. Illumina 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. Agilent Technologies 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5 Geneva Bioinformatics (Genebio) 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6 Dassault Systems 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. Bruker Daltonics 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8. Biomax Informatics AG 15.8.1. Company Overview 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9. Perkinelmer 15.9.1. Company Overview 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10. Qiagen N.V 15.10.1. Company Overview 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 15.11. Accelrys 15.11.1. Company Overview 15.11.2. Product Portfolio 15.11.3. SWOT Analysis 15.11.4. Financial Overview 15.11.5. Strategic Overview 15.12. Affymetrix 15.12.1. Company Overview 15.12.2. Product Portfolio 15.12.3. SWOT Analysis 15.12.4. Financial Overview 15.12.5. Strategic Overview 15.13. SA Nonlinear Dynamics 15.13.1. Company Overview 15.13.2. Product Portfolio 15.13.3. SWOT Analysis 15.13.4. Financial Overview 15.13.5. Strategic Overview 15.14. Quest Diagnostics 15.14.1. Company Overview 15.14.2. Product Portfolio 15.14.3. SWOT Analysis 15.14.4. Financial Overview 15.14.5. Strategic Overview 15.15. IBM Life Sciences 15.15.1. Company Overview 15.15.2. Product Portfolio 15.15.3. SWOT Analysis 15.15.4. Financial Overview 15.15.5. Strategic Overview 16. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics